Genomics refers to the study of an entire set of DNA within an organism. This includes researching their molecular components, structures and functions of genes, and developing technologies that map and edit sequences of DNA. What started as a global scientific endeavor to map the human genome in the 1990s has unintentionally created an entirely new business market, whereby companies use genomic technologies to provide personal, direct-to-consumer genomic testing services. This enabled consumers to gain unprecedented insights into their current and forecasted health conditions and even family ancestry, all from a genomic perspective.
Scope
This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
The report covers the genomics theme.
Reasons to Buy
GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
Develop and design your corporate strategies through an in-house expert analysis of genomics by understanding the primary ways in which this theme is impacting the healthcare industry.
Stay up to date on the industry’s major players and where they sit in the value chain.
Identify emerging industry trends to gain a competitive advantage.